Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyThomas W. Flaig, Alyse Johnson-Chilla|Journal of the National Comprehensive Cancer Network|2020Cited by 627
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyJohn A. Thompson, Jillian L. Scavone, Marianne Davies et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 560
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A. Thompson, Anita M. Engh, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 484
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018Robert I. Haddad, Lisa A. Gurski, Christian Nasr et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 370